Measurements of h(c)(1P(1)) in psi' decays

We present measurements of the charmonium state h(c)(1P(1)) made with 106x10(6) psi' events collected by BESIII at BEPCII. Clear signals are observed for psi'-->pi0 h(c) with and without the subsequent radiative decay h(c)-->gamma eta(c). First measurements of the absolute branching ratios B(psi'-->pi0 h(c)) = (8.4+/-1.3+/-1.0) x 10(-4) and B(h(c)-->gamma eta(c)) = (54.3+/-6.7+/-5.2)% are presented. A statistics-limited determination of the previously unmeasured h(c) width leads to an upper limit Gamma(h(c))<1.44 MeV (90% confidence). Measurements of M(h(c)) = 3525.40+/-0.13+/-0.18 MeV/c2 and B(psi'-->pi0 h(c)) x B(h(c)-->gamma eta(c)) = (4.58+/-0.40+/-0.50) x 10(-4) are consistent with previous results.

Improving the privacy of optical steganography with temporal phase masks

Temporal phase modulation of spread stealth signals is proposed and demonstrated to improve optical steganography transmission privacy. After phase modulation, the temporally spread stealth signal has a more complex spectral-phase-temporal relationship, such that the original temporal profile cannot be restored when only dispersion compensation is applied to the temporally spread stealth signals. Therefore, it increases the difficulty for the eavesdropper to detect and intercept the stealth channel that is hidden under a public transmission, even with a correct dispersion compensation device. The experimental results demonstrate the feasibility of this approach and display insignificant degradation in transmission performance, compared to the conventional stealth transmission without temporal phase modulation. The proposed system can also work without a clock transmission for signal synchronization. Our analysis and simulation results show that it is difficult for the adversary to detect the existence of the stealth transmission, or find the correct phase mask to recover the stealth signals.

Adenovirus-mediated leptin expression normalises hypertension associated with diet-induced obesity

In our previous study, moderate increases in plasma leptin levels achieved via administration of recombinant adenovirus containing the rat leptin cDNA were shown to correct the abnormal metabolic profile in rats with diet-induced obesity, suggesting that these animals had developed resistance to the metabolic effects of leptin, which could be reversed by leptin gene over-expression. However, the effect of this therapeutic strategy on blood pressure was not investigated. The present study aimed to determine whether a moderate increase of endogenous plasma leptin levels affected arterial blood pressure in rats with diet-induced obesity and hypertension. The major finding from the present study was that the natural rise in plasma leptin with weight-gain is insufficient to counterbalance high blood pressure associated with obesity, additional increases of circulating leptin levels with adenoviral leptin gene therapy led to normalisation of blood pressure in high-fat diet-induced obese and hypertensive rats. Mechanistically, the reduction of blood pressure by leptin in obese rats was likely independent of alpha-adrenergic and acetylcholinergic receptor mediation. This is the first study to demonstrate that further increases in circulating leptin levels by leptin gene transfer during obesity could reduce blood pressure.

Palmitic acid and docosahexaenoic acid opposingly regulate the expression of insulin-degrading enzyme in neurons

Previous results show that treatment with saturated fatty acids, such as palmitic acid (PA), induces the pathology of Alzheimer's disease (AD), while treatment with polyunsaturated fatty acids, such as docosahexaenoic acid (DHA), protects against AD pathology. However, the pharmacological mechanism underlying these opposite effects of fatty acids on AD is not well understood. Here, we show that PA treatment significantly reduced the expression of insulin-degrading enzyme (IDE), an important protease responsible for the degradation of amyloid-beta (A beta) in neural cells, while incubation with DHA up-regulated IDE levels in primary hippocampal neurons. Moreover, pre-incubation with PA attenuated the DHA-induced IDE expression. Taken together, these results suggest the opposite effects of saturated fatty acids and polyunsaturated fatty acids on the expression of IDE, indicating a novel mechanism underlying the pharmacological function of fatty acids in AD intervention.

Transitory blocking of pulmonary artery and veins as a novel strategy in pulmonary surgery: an experimental study in a rabbit model

BACKGROUNDS

Transitory blocking of the pulmonary artery and veins is now being applied in the treatment of local advanced non-small cell lung cancer in our department. We performed this study to establish a pulmonary vessel blocking model in rabbits and investigate the features of lung ischemia-reperfusion injury.

METHODS

126 New Zealand rabbits were randomized into 3 groups: group I, sham group; group II, left pulmonary artery blocking, and group III, left pulmonary artery and veins blocking. The physiological data as well as the blood and tissue samples were harvested at the time of thoracotomy, at 1 h after ischemia and 1, 2, 4, 6 and 24 h after reperfusion, respectively. Lung injury was assessed histologically by determining the levels of malondialdehyde, superoxide dismutase, myeloperoxidase and water content.

RESULTS

The hemodynamics were stable in all three groups. The levels of malondialdehyde, myeloperoxidase, and water content of lung tissue were all significantly increased in groups II and III when compared with group I at 1, 2, 4 and 6 h after reperfusion. They almost all returned to baseline at 24 h after reperfusion. However, there was no significant difference observed between groups II and III at either time point. A similar change in the process of lung ischemia-reperfusion injury was observed under light and electron microscopes in group II and in group III.

CONCLUSIONS

The features of lung ischemia-reperfusion injury were similar when blocking the pulmonary artery and veins compared with blocking the pulmonary artery alone. Moreover, it might be safe to block the pulmonary vessels within 1 h during pulmonary surgery.

Age-related accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch's membrane

Age-related macular degeneration (AMD) is a disease leading to severe visual loss and legal blindness in the elderly population. The pathophysiology of AMD is complex and may include genetic predispositions, accumulation of lipofuscin and drusen, local inflammation and neovascularization. Recently four independent research groups have identified a commonly inherited variant (Y402H) of the complement factor H gene in the genome from different groups of AMD patients. The Y402H variant of CFH significantly increases the risk of AMD and links the genetics of the disease with inflammation. During inflammation there is activation of inducible nitric oxide synthase and release of nitric oxide, which in principal could lead to non-enzymatic nitration within extracellular deposits and/or intrinsic extracellular matrix protein components of human Bruch's membrane. We have identified two biomarkers for non-enzymatic nitration in aged human Bruch's membrane, indicative of inflammation, that include 3-nitrotyrosine identified in Bruch's membrane preparations and nitrated A2E from the lipid soluble extract of the Bruch's membrane preparation. Approximately 30-40 times more A2E is observed in samples of the organic soluble extract of lipofuscin compared to the extract of Bruch's membrane. It is of interest to note that although A2E is a major constituent of RPE lipofuscin, nitrated A2E could not be detected in RPE extracts. We show here that nitro-A2E is a specific biomarker of nitrosative stress in Bruch's membrane and its concentration correlates directly with tissue age.

Radiation dose to the lens using different temporal bone CT scanning protocols

BACKGROUND AND PURPOSE

Temporal bone CT is performed frequently in clinical practice. At the same time, the eye lens are exposed to ionizing radiation without any useful diagnostic information delivered. Our aim was to investigate the radiation dose to the lens of the eye by using temporal bone CT scanning with different protocols.

MATERIALS AND METHODS

Direct axial and coronal CT by using a conventional sequential scanning mode (140 kV, 220 mAs/section, 1.25-mm thickness, 1.25-mm increment, 16 x 0.625 mm collimation, the glabellomeatal line as a scanning baseline), a routine helical scanning mode (140 kV, 220 mAs/section, 0.315 pitch, 0.67-mm thickness, 0.33-mm increment, 16 x 0.625 collimation, the orbitomeatal line as a scanning baseline), and a modified helical scanning mode (acanthiomeatal line as a scanning baseline; other parameters, same as above) was performed on an exsomatized cadaveric head. CTDI(vol) and DLP were recorded for each scanning mode, and effective doses were calculated. Organ doses for the lens were measured with TLDs.

RESULTS

When the sequential scanning mode was used, the gross effective dose was 1.21 mSv and the organ dose to the lens was 50.96 and 1.73 mGy, respectively, for direct axial and coronal imaging. The effective dose was 0.803 mSv in routine helical scanning, while the lens dose was 40.17 mGy. With the modified helical scanning mode, the effective dose was as same as that for the routine helical scanning, but the lens dose was reduced significantly to 10.33 mGy.

CONCLUSIONS

The effective doses resulting from sequential axial and coronal scanning were 1.51 times higher than the dose from helical scanning, and the lens dose was 1.31 times higher. With the modified helical scanning mode, thinner section images could be used to reformat axial, coronal, and sagittal images with a further 74.3% reduction in lens dose beyond that achieved with the conventional helical protocol.

Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum

The protective effect of an iridoid catalpol extracted and purified from the traditional Chinese medicinal herb Rehmannia glutinosa on the neuronal degeneration of nigral-striatal dopaminergic pathway was studied in a chronic 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP)/probenecid C57BL/6 mouse model and in 1-methyl-4-phenylpyridimium (MPP(+)) intoxicated cultured mesencephalic neurons. Rotarod performance revealed that the locomotor ability of mice was significantly impaired after completion of model production and maintained thereafter for at least 4 weeks. Catalpol orally administered for 8 weeks (starting from the second week of model production) dose dependently improved the locomotor ability. HPLC revealed that catalpol significantly elevated striatal dopamine levels without changing the metabolite/dopamine ratios. Nor did it bind to dopamine receptors. Therefore it is unlikely that catalpol resembles any of the known compounds for treating Parkinsonism. Instead, catalpol dose dependently raised the tyrosine hydroxylase (TH) neuron number in substantia nigra pars compacta (SNpc), the striatal dopamine transporter (DAT) density and the striatal glial cell derived neurotrophic factor (GDNF) protein level. Linear regression revealed that both the TH neuron number and DAT density were positively correlated to the GDNF level. In the cultured mesencephalic neurons, MPP(+) decreased the dopaminergic neuron number and shortened the neurite length, whereas catalpol showed protective effect dose dependently. Furthermore, the expression of GDNF mRNA was up-regulated by catalpol to a peak nearly double of normal control in neurons intoxicated with MPP(+) for 24 h but not in normal neurons. The GDNF receptor tyrosine kinase RET inhibitor 4-amino-5-(4-methyphenyl)-7-(t-butyl)-pyrazolo-[3,4-d]pyrimidine (PP1) abolished the protective effect of catalpol either partially (TH positive neuron number) or completely (neurite length). Taken together, catalpol improves locomotor ability by attenuating the neuronal degeneration of nigral-striatal dopaminergic pathway, and this attenuation is at least partially through elevating the striatal GDNF expression.